UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000037387
Receipt No. R000042626
Scientific Title A Study to investigate the influence of diet on plasma levodopa concentration during LCIG therapy
Date of disclosure of the study information 2019/07/16
Last modified on 2019/07/16 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A Study to investigate the influence of diet on plasma levodopa concentration during LCIG therapy
Acronym Influence of diet on LCIG therapy
Scientific Title A Study to investigate the influence of diet on plasma levodopa concentration during LCIG therapy
Scientific Title:Acronym Influence of diet on LCIG therapy
Region
Japan

Condition
Condition Parkinson's disease
Classification by specialty
Neurology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the influence of lunch intake on plasma levodopa concentration and clinical symptoms during LCIG therapy
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Plasma levodopa concentration with or without lunch (including 20-25 g of protein)
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Food
Interventions/Control_1 with or without lunch
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients with Parkinson's disease who undergo LCIG therapy
Key exclusion criteria Patients who have difficulty showing consent
Target sample size 10

Research contact person
Name of lead principal investigator
1st name Yuko
Middle name
Last name Hosokawa
Organization Ehime University Hospital
Division name Department of Neurology and Clinical Pharmacology
Zip code 791-0295
Address 454, shitsukawa Tohon, Ehime, Japan
TEL 089-960-5095
Email hosokawa.yuko.ks@ehime-u.ac.jp

Public contact
Name of contact person
1st name Yuko
Middle name
Last name Hosokawa
Organization Ehime University Hospital
Division name Department of Neurology and Clinical Pharmacology
Zip code 791-0295
Address 454, shitsukawa Tohon, Ehime, Japan
TEL 089-960-5095
Homepage URL
Email hosokawa.yuko.ks@ehime-u.ac.jp

Sponsor
Institute Department of Neurology and Clinical Pharmacology, Ehime University Hospital
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor Saiseikai Matsuyama Hospital
Name of secondary funder(s)

IRB Contact (For public release)
Organization Institutional Review Board ,Ehime University Hospital
Address Tohon, Ehime, Japan
Tel 089-960-5914
Email rinri@m.ehime-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 07 Month 16 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2019 Year 06 Month 11 Day
Date of IRB
Anticipated trial start date
2019 Year 07 Month 01 Day
Last follow-up date
2024 Year 06 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2019 Year 07 Month 16 Day
Last modified on
2019 Year 07 Month 16 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042626